CORAL GABLES, Fla., Oct. 08, 2024 (GLOBE NEWSWIRE) -- ("Catalyst" or "the Company") (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused on in-licensing, developing, and ...
In its latest quarterly filing with the U.S. Securities and Exchange Commission, the bank disclosed that authorities were investigating issues related to its AML and sanctions programs. (Reporting by ...